Project Details
| Short title | AVZO-021-1001 |
|---|---|
| Status | Finished |
| Effective start/end date | 4/12/24 → 13/11/25 |
CTU: A Phase 1/2, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Anti-Tumour Activity of AVZO-021 as a Single Agent and in Combination Therapy in Patients with Advanced Solid Tumors
- Sabanathan, Dhanusha (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Quinlan, Gabriel (Clinical Trial Unit Staff)
- TAIDI, Gina (Clinical Trial Unit Staff)
- Martin, Lewis (Clinical Trial Unit Staff)
- Garcia, Michelle (Clinical Trial Unit Staff)
- Armstrong, Emilia (Clinical Trial Unit Staff)
Project: Research